Physician profile
Bryna Kane
NPI 1831171842
$3,182.53
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $107 · 2021: $387 · 2022: $1,256 · 2023: $650 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $577.84 | 2019-2024 | |
| Merz North America, INC. | $511.13 | 2021-2022 | |
| Abbvie INC. | $303.27 | 2019-2023 | |
| Allergan, INC. | $195.78 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $162.97 | 2021-2023 | Dupixent |
| Janssen Biotech, INC. | $130.88 | 2021-2023 | Tremfya |
| Glaxosmithkline, LLC. | $119.92 | 2023 | Shingrix |
| Incyte Corporation | $102.11 | 2021-2023 | Opzelura |
| Ucb, INC. | $98.82 | 2019-2022 | |
| Lilly USA, LLC | $96.03 | 2019-2023 | Olumiant, Taltz |
| Pfizer INC. | $88.10 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $81.08 | 2019-2023 | |
| Leo Pharma INC. | $72.37 | 2019-2023 | Adbry |
| Novartis Pharmaceuticals Corporation | $71.06 | 2019-2022 | |
| Biofrontera INC. | $68.68 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $60.92 | 2019-2023 | Winlevi, Absorica Ld |
| Almirall LLC | $54.96 | 2023 | Seysara, Klisyri |
| Amgen INC. | $52.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $39.67 | 2023 | Sotyktu |
| Prugen, INC. Pharmaceuticals | $32.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.43 | 2022 | |
| Journey Medical Corporation | $28.56 | 2022 | |
| Genentech USA, INC. | $27.27 | 2019 | |
| Lifenet Health | $25.57 | 2023 | |
| Aclaris Therapeutics, INC. | $25.40 | 2019 | |
| Dusa Pharmaceuticals, INC. | $23.64 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $20.92 | 2019 | |
| Vyne Pharmaceuticals INC. | $17.36 | 2020 | |
| Merck Sharp & Dohme LLC | $16.54 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.30 | 2019 | |
| Strata Skin Sciences, INC. | $15.30 | 2022 | |
| Galderma Laboratories, L.P. | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryna Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.